HLA antigens in patients with unexplained hepatitis following halothane anesthesia

Acta Anaesthesiol Scand. 1985 Jul;29(5):497-501. doi: 10.1111/j.1399-6576.1985.tb02242.x.

Abstract

We examined HLA-A,B,C and DR locus antigens in 38 Japanese patients who had recovered from halothane hepatitis. The patients were divided into two subgroups, i.e. jaundice and non-jaundice groups, because the clinical features were quite different in each. DR2 was positive in 14 (58.3%) of 24 patients with jaundice, compared with 281 (33.6%) of the 837 Japanese healthy controls (chi-square with Yates' correction = 5.30, relative risk = 2.77, P less than 0.025). Conversely, Bw44 was increased in non-jaundice patients (50.0%), compared with 157 (12.7%) of the 1234 Japanese healthy controls (chi-square with Yates' correction = 13.75, relative risk = 6.86, P less than 0.001). The haplotype frequency (Hf) of Aw24-Bw52-DR2 was high in the patients with jaundice (Hf = 0.2362), while it was zero in the patients without jaundice (P less than 0.0042). These data suggest that the two groups of halothane hepatitis have different genetic backgrounds.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anesthetics / adverse effects*
  • Anesthetics / metabolism
  • Chemical and Drug Induced Liver Injury / etiology*
  • Chemical and Drug Induced Liver Injury / genetics
  • Chemical and Drug Induced Liver Injury / immunology
  • Child
  • Cholestasis, Intrahepatic / chemically induced
  • Disease Susceptibility
  • Female
  • HLA Antigens / analysis*
  • HLA-DR Antigens
  • Halothane / adverse effects*
  • Halothane / metabolism
  • Histocompatibility Antigens Class II / analysis
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Obesity / complications
  • Obesity / metabolism

Substances

  • Anesthetics
  • HLA Antigens
  • HLA-DR Antigens
  • Histocompatibility Antigens Class II
  • Halothane